14.07.2017
- The UK Supreme Court has ruled in favor of US drugmaker Eli Lilly in a patent dispute with generics producer Actavis, now owned by Israel’s Teva, over the cancer drug Alimta. The...
03.05.2017
- Major pharmaceutical producers threaten to lose $26.5 billion in annual sales this year, as 18 branded drugs are due to expire, analysts for investment bank Bernstein said in a...
25.04.2017
- Pharma chiefs are urging European heads of state to decide sooner rather than later on the new location for the European Medicines Agency (EMA), which is due to leave the UK as a...
05.04.2017
- US drugmaker Eli Lilly has announced plans to invest $850 million in its US operations during 2017, including an $85 million expansion of its Trulicity (dulaglutide) device...
22.03.2017
- The US Food and Drug Administration (FDA) has approved Novartis’ new drug Kisqali (ribociclib) as an initial treatment for postmenopausal women with a type of metastatic breast...
24.02.2017
- In a letter to the leadership of the US Congress, 16 CEOs of major American companies, including Pfizer’s Ian Read, Eli Lilly’s David Ricks, Merck & Co’s Ken Frazier and Celgene’s...
01.02.2017
- In a meeting at the White House on Jan. 31, new US president, Donald Trump, held out both a carrot and a stick to pharmaceutical producers. The industry will “have to “get prices...
23.01.2017
- Eli Lilly is paying around $960 million to acquire biopharma CoLucid, boosting the US drugmaker’s portfolio for migraine pain management and adding a late-stage candidate with a...
